Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
PT-141: Cyclic heptapeptide derived from MT-2 with primary activity at MC4R in the hypothalamus for sexual desire
This page is general information, not medical advice
Patients with severe kidney disease or end-stage renal disease may not be appropriate candidates for this therapy, particularly if they have significant fluid retention or are prone to dehydration
4.2 Proteins Besides direct changes, ROS can indirectly affect proteins
Its slow-release properties make it an excellent choice for those seeking sustained benefits
US$ 23.93
US$ 24.48
US$ 24.93
